These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 9727009

  • 1. Bcl-2 activates the transcription factor NFkappaB through the degradation of the cytoplasmic inhibitor IkappaBalpha.
    de Moissac D, Mustapha S, Greenberg AH, Kirshenbaum LA.
    J Biol Chem; 1998 Sep 11; 273(37):23946-51. PubMed ID: 9727009
    [Abstract] [Full Text] [Related]

  • 2. Bcl-2 intersects the NFkappaB signalling pathway and suppresses apoptosis in ventricular myocytes.
    Kirshenbaum LA.
    Clin Invest Med; 2000 Oct 11; 23(5):322-30. PubMed ID: 11055326
    [Abstract] [Full Text] [Related]

  • 3. Linkage of the BH4 domain of Bcl-2 and the nuclear factor kappaB signaling pathway for suppression of apoptosis.
    de Moissac D, Zheng H, Kirshenbaum LA.
    J Biol Chem; 1999 Oct 08; 274(41):29505-9. PubMed ID: 10506215
    [Abstract] [Full Text] [Related]

  • 4. Activation of nuclear factor kappaB and Bcl-x survival gene expression by nerve growth factor requires tyrosine phosphorylation of IkappaBalpha.
    Bui NT, Livolsi A, Peyron JF, Prehn JH.
    J Cell Biol; 2001 Feb 19; 152(4):753-64. PubMed ID: 11266466
    [Abstract] [Full Text] [Related]

  • 5. Pervanadate-induced nuclear factor-kappaB activation requires tyrosine phosphorylation and degradation of IkappaBalpha. Comparison with tumor necrosis factor-alpha.
    Mukhopadhyay A, Manna SK, Aggarwal BB.
    J Biol Chem; 2000 Mar 24; 275(12):8549-55. PubMed ID: 10722693
    [Abstract] [Full Text] [Related]

  • 6. IKK beta is required for Bcl-2-mediated NF-kappa B activation in ventricular myocytes.
    Regula KM, Ens K, Kirshenbaum LA.
    J Biol Chem; 2002 Oct 11; 277(41):38676-82. PubMed ID: 12167626
    [Abstract] [Full Text] [Related]

  • 7. A direct requirement of nuclear factor-kappa B for suppression of apoptosis in ventricular myocytes.
    Mustapha S, Kirshner A, De Moissac D, Kirshenbaum LA.
    Am J Physiol Heart Circ Physiol; 2000 Sep 11; 279(3):H939-45. PubMed ID: 10993753
    [Abstract] [Full Text] [Related]

  • 8. Tumor necrosis factor-alpha-inducible IkappaBalpha proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-kappab activation.
    Han Y, Weinman S, Boldogh I, Walker RK, Brasier AR.
    J Biol Chem; 1999 Jan 08; 274(2):787-94. PubMed ID: 9873017
    [Abstract] [Full Text] [Related]

  • 9. Role of IkappaBalpha ubiquitination in signal-induced activation of NFkappaB in vivo.
    Roff M, Thompson J, Rodriguez MS, Jacque JM, Baleux F, Arenzana-Seisdedos F, Hay RT.
    J Biol Chem; 1996 Mar 29; 271(13):7844-50. PubMed ID: 8631829
    [Abstract] [Full Text] [Related]

  • 10. Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms.
    Li N, Karin M.
    Proc Natl Acad Sci U S A; 1998 Oct 27; 95(22):13012-7. PubMed ID: 9789032
    [Abstract] [Full Text] [Related]

  • 11. Endotoxin stress-response in cardiomyocytes: NF-kappaB activation and tumor necrosis factor-alpha expression.
    Wright G, Singh IS, Hasday JD, Farrance IK, Hall G, Cross AS, Rogers TB.
    Am J Physiol Heart Circ Physiol; 2002 Mar 27; 282(3):H872-9. PubMed ID: 11834481
    [Abstract] [Full Text] [Related]

  • 12. IkappaBalpha gene therapy in tumor necrosis factor-alpha- and chemotherapy-mediated apoptosis of hepatocellular carcinomas.
    Tietze MK, Wuestefeld T, Paul Y, Zender L, Trautwein C, Manns MP, Kubicka S.
    Cancer Gene Ther; 2000 Oct 27; 7(10):1315-23. PubMed ID: 11059688
    [Abstract] [Full Text] [Related]

  • 13. Effect of NF-kappa B Inhibition on TNF-alpha-induced apoptosis and downstream pathways in cardiomyocytes.
    Bergmann MW, Loser P, Dietz R, von Harsdorf R.
    J Mol Cell Cardiol; 2001 Jun 27; 33(6):1223-32. PubMed ID: 11444925
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of NFkappaB in activated rat hepatic stellate cells by proteasome inhibitors and an IkappaB super-repressor.
    Hellerbrand C, Jobin C, Iimuro Y, Licato L, Sartor RB, Brenner DA.
    Hepatology; 1998 May 27; 27(5):1285-95. PubMed ID: 9581682
    [Abstract] [Full Text] [Related]

  • 15. A mechanistic insight into a proteasome-independent constitutive inhibitor kappaBalpha (IkappaBalpha) degradation and nuclear factor kappaB (NF-kappaB) activation pathway in WEHI-231 B-cells.
    Shumway SD, Miyamoto S.
    Biochem J; 2004 May 15; 380(Pt 1):173-80. PubMed ID: 14763901
    [Abstract] [Full Text] [Related]

  • 16. The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression.
    Tran NL, McDonough WS, Savitch BA, Sawyer TF, Winkles JA, Berens ME.
    J Biol Chem; 2005 Feb 04; 280(5):3483-92. PubMed ID: 15611130
    [Abstract] [Full Text] [Related]

  • 17. Arsenic inhibits NF-kappaB-mediated gene transcription by blocking IkappaB kinase activity and IkappaBalpha phosphorylation and degradation.
    Roussel RR, Barchowsky A.
    Arch Biochem Biophys; 2000 May 01; 377(1):204-12. PubMed ID: 10775461
    [Abstract] [Full Text] [Related]

  • 18. Ubiquitin/proteasome-dependent degradation of D-type cyclins is linked to tumor necrosis factor-induced cell cycle arrest.
    Hu X, Bryington M, Fisher AB, Liang X, Zhang X, Cui D, Datta I, Zuckerman KS.
    J Biol Chem; 2002 May 10; 277(19):16528-37. PubMed ID: 11864973
    [Abstract] [Full Text] [Related]

  • 19. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation.
    Desterro JM, Rodriguez MS, Hay RT.
    Mol Cell; 1998 Aug 10; 2(2):233-9. PubMed ID: 9734360
    [Abstract] [Full Text] [Related]

  • 20. Bortezomib inhibits proteasomal degradation of IκBα and induces mitochondrial dependent apoptosis in activated B-cell diffuse large B-cell lymphoma.
    Bu R, Hussain AR, Al-Obaisi KA, Ahmed M, Uddin S, Al-Kuraya KS.
    Leuk Lymphoma; 2014 Feb 10; 55(2):415-24. PubMed ID: 23697845
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.